Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reduction of Abdominal Obesity and Insulin Resistance in Women

This study has been completed.
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by:
Queen's University
ClinicalTrials.gov Identifier:
NCT00664495
First received: April 21, 2008
Last updated: April 22, 2008
Last verified: April 2008
  Purpose

The purpose of the study was to assess the effects of equivalent diet- or exercise-induced weight loss and related insulin resistance in abdominally obese women.


Condition Intervention
Obesity
Behavioral: Diet Weight Loss
Behavioral: Exercise Weight Loss
Behavioral: Exercise Without Weight Loss

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Official Title: Reduction of Abdominal Obesity and Insulin Resistance in Women

Resource links provided by NLM:


Further study details as provided by Queen's University:

Primary Outcome Measures:
  • Abdominal Obesity [ Time Frame: 4 months ] [ Designated as safety issue: No ]
  • Insulin Resistance [ Time Frame: 4 Months ] [ Designated as safety issue: No ]

Study Start Date: April 1999
Study Completion Date: December 2003
Primary Completion Date: December 2003 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: C
Control
Active Comparator: DWL
Diet Weight Loss
Behavioral: Diet Weight Loss
Active Comparator: EWL
Exercise Weight Loss
Behavioral: Exercise Weight Loss
Active Comparator: EWS
Exercise Without Weight Loss
Behavioral: Exercise Without Weight Loss

  Eligibility

Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Premenopausal women

Exclusion Criteria:

  • Smokers and diabetics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00664495

Locations
Canada, Ontario
Queen's University
Kingston, Ontario, Canada, K7L 3N6
Sponsors and Collaborators
Queen's University
Canadian Institutes of Health Research (CIHR)
Investigators
Principal Investigator: Robert Ross, PhD Queen's University
  More Information

Publications:
Responsible Party: Queen's University
ClinicalTrials.gov Identifier: NCT00664495     History of Changes
Other Study ID Numbers: Ross 1999
Study First Received: April 21, 2008
Last Updated: April 22, 2008
Health Authority: Canada: Canadian Institutes of Health Research

Keywords provided by Queen's University:
Obesity, exercise, diet, insulin resistance

Additional relevant MeSH terms:
Insulin Resistance
Obesity
Obesity, Abdominal
Body Weight
Glucose Metabolism Disorders
Hyperinsulinism
Metabolic Diseases
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Insulin
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on November 20, 2014